Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Interview with Xspray Pharma - Per Andersson, CEO at Xspray Pharma
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Interview with Xspray Pharma - Per Andersson, CEO at Xspray Pharma
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Journey Through Economic Challenges: A Perspective from UK Banking | Charlie Nunn, CEO, Lloyds Banking Group.
00:10:00
Archer Materials successfully fabricates nanosize biosensor components for its biochip | Dag Skindlo, CEO, Archer LtdARCH:OSL
00:10:00
Interview with Carlos and Takara: Founder & CEO of Novel Capital on Non-Dilutive Financing for Entrepreneurs
00:10:00
Siriphong Aunthornphan and AIT's move into the AEC market|CEO , Advanced Information Technology Public Company Limited
00:10:00
Capral Limited at the ASX Small and Mid-Cap Conference with Proactive | MR TONY DRAGICEVICH., CHIEF EXECUTIVE OFFICER AND MANAGING DIRECTOR, CAPRAL LTD
00:10:00
Nothing can stop you if know what is the right path|Zavain Dar,Partner, Lux Capital
00:10:00
Ohio Educators Can Now Deduct $250 on State Taxes: What You Need to Know | Ken Robinson, Owner, Practical Financial Planning.
00:10:00
Revolutionizing Finance: The Next Best Action Advantage| Paul O'Donnell , President & CEO at NexJ Systems
00:10:00
Unlock business potential with CMG Cloud, offering scalable solutions, latest software releases, and secure global access to enhance project delivery and productivity.|Pramod Jain is the CEO of Computer Modelling Group
00:10:00
"Navigating Q1FY25 Challenges and Opportunities: Hiren Ved's Analysis of Market Trends, Capital Expenditure, and Economic Momentum"
00:10:00
The Future For Aptitude Software Limited|CFO , Aptitude Software Group PLC
00:10:00
Jeffrey Lipson, president and CEO of HASI, joins 'The Exchange' to discuss the company's financial strategies and sustainability focus.